National Alert: Blood Pressure Medication Recalled Over Packaging Mix-Up
Health Canada has issued a national alert regarding a recall of specific blood pressure medication. Two lots of MAR-Amlodipine 5 mg tablets are affected due to a packaging error.
Recall Details
Marcan Pharmaceuticals Inc. has confirmed that certain bottles labeled as MAR-Amlodipine may contain midodrine 2.5 mg tablets instead. Midodrine is prescribed to treat low blood pressure, while MAR-Amlodipine is intended for high blood pressure and chest pain.
Health Risks
The consumption of midodrine rather than amlodipine could result in serious health complications. Risks include:
- Dangerously high blood pressure
- Dizziness
- Fainting
- Slow heartbeats
- Potential organ damage
Children are particularly susceptible to severe side effects if they inadvertently consume the incorrect medication.
Affected Product Information
The specific products involved in the recall are:
| Product Name | Drug Identification Number (DIN) | Lot Numbers | Expiry Date |
|---|---|---|---|
| MAR-Amlodipine 5 mg | 02371715 | 2472021, 2472021A | July 2027 |
Identifying the Correct Medication
The authentic amlodipine tablets are white to off-white, flat, and eight-sided with specific markings. One side features “210” and “5,” while the other side is left blank. In contrast, the incorrect midodrine tablets are white, round, and marked with “M2” on one side.
Immediate Action Required
Health Canada urges patients to inspect their medication immediately. If bottles contain round tablets or if there is doubt about the contents, they should be returned to the pharmacy.
Patients are advised against consuming any round tablets. Anyone who experiences symptoms such as dizziness, elevated blood pressure, or slow heartbeats should contact a healthcare professional or dial 911. Immediate medical care is necessary for symptoms like chest pain and sudden headaches.
Follow-Up and Contact Information
Health Canada is actively monitoring the recall and the ongoing investigation by Marcan Pharmaceuticals. Consumers with questions can reach out to the company directly. Additionally, healthcare professionals are urged to verify the contents of medications prior to dispensing.
